Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AHP/Interneuron Redux NEJM editorial reiterates authors' advisory cmte. presentations for sponsors.

Executive Summary

REDUX NEJM EDITORIAL REITERATES ADVISORY CMTE. PRESENTATIONS made by the authors of the editorial, JoAnn Manson, MD/PhD, Harvard Medical School, and former FDA Office of Epidemiology and Biostatistics Director Gerald Faich, MD, University of Pennsylvania, during the Sept. 28 and Nov. 16 review of Wyeth-Ayerst/Interneuron's obesity therapy Redux (dexfenfluramine). Manson and Faich have been criticized for failing to properly disclose their consulting arrangements with Wyeth and Interneuron to the New England Journal of Medicine.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS028759

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel